ask="5.74"
ask_size="600"
average_daily_volume="35276"
bid="3.75"
bid_size="1600"
book_value="2.20"
change="+0.04"
change_from_200_day_moving_average="1.76"
change_from_50_day_moving_average="1.06"
change_from_52_week_high="-1.75"
change_From_52_week_low="2.61"
change_in_percent="+0.71%"
close="5.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.80"
ebitda="-3.26M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="3212000"
high="5.66"
high_52_weeks="7.40"
last_trade_date="2/16/2017"
last_trade_price="5.65"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.40"
low_52_weeks="3.04"
market_capitalization="19.08M"
moving_average_200_day="3.89"
moving_average_50_day="4.59"
name="BiondVax Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="15.00"
open="5.55"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+45.15%"
percent_change_from_50_day_moving_average="+23.03%"
percent_change_from_52_week_high="-23.65%"
percent_change_from_52_week_low="+85.86%"
previous_close="5.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="3377000"
short_ratio="0.26"
stock_exchange="NCM"
symbol="BVXV"
volume="9783"
weeks_range_52="3.04 - 7.40"
